Clinical trial / 2010
B vitamins slowed brain atrophy rates in older adults with mild cognitive impairment
In a randomized trial, 168 older adults with mild cognitive impairment received daily B vitamins (0.8 mg folic acid, 0.5 mg B12, 20 mg B6) or placebo for 24 months. Brain atrophy averaged 0.76% per year in the active group versus 1.08% with placebo (P = 0.001). The response was greater among individuals with baseline homocysteine above 13 micromol/L, whose atrophy rate dropped by 53% (P = 0.001). Faster atrophy was linked to lower cognitive test scores.
- Study type
- Randomized controlled trial
- Who was studied
- 168 older adults with mild cognitive impairment
- What was measured
- Whole-brain atrophy rate
THE PAPER
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H. PLoS One, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.